Asset Details
Do you wish to reserve the book?
Widespread diabetes screening for cardiovascular disease risk estimation
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Widespread diabetes screening for cardiovascular disease risk estimation
Do you wish to request the book?
Widespread diabetes screening for cardiovascular disease risk estimation
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Widespread diabetes screening for cardiovascular disease risk estimation
2021
Overview
[...]in the Multi-Ethnic Study of Atherosclerosis, diabetes was among the risk factors that were associated with risk overestimation in a single-variable analysis.2 Since the early 2000s, the New Zealand Ministry of Health has recommended the use of cardiovascular disease risk prediction to inform preventive treatment decisions, and that recommendation resulted in an increase in screening for diabetes status. [...]in 2012, only 50% of eligible adults had been screened for diabetes. [...]New Zealand created a new national initiative to increase screening for diabetes in the eligible population, which replaced fasting blood glucose with non-fasting glycated haemoglobin (HbA1c) as the recommended screening test. Global diabetes prevalence is increasing from the rise in obesity, unhealthy diets, and widespread physical inactivity due in part to growing urbanisation and its impact on lifestyle factors.4 This increasing prevalence, in addition to the adoption of cardiovascular disease risk estimation by many countries that require screening for diabetes, will increase the heterogeneity of the cardiovascular disease risk profile among individuals with diabetes. Since many primary prevention guidelines from national organisations around the world consider patients with diabetes at high cardiovascular risk, these guidelines require re-examination when diabetes screening levels are high.
Publisher
Elsevier Ltd,Elsevier Limited
We currently cannot retrieve any items related to this title. Kindly check back at a later time.